125 related articles for article (PubMed ID: 21209620)
1. Role of STAT3 Locus in autoimmune diseases.
Jabalameli MR
Genes Immun; 2011 Mar; 12(2):155; author reply 156. PubMed ID: 21209620
[No Abstract] [Full Text] [Related]
2. STAT3 locus in inflammatory bowel disease and multiple sclerosis susceptibility.
Cénit MC; Alcina A; Márquez A; Mendoza JL; Díaz-Rubio M; de las Heras V; Izquierdo G; Arroyo R; Fernández O; de la Concha EG; Matesanz F; Urcelay E
Genes Immun; 2010 Apr; 11(3):264-8. PubMed ID: 20200543
[TBL] [Abstract][Full Text] [Related]
3. Genetics of multiple sclerosis.
Hoppenbrouwers IA; Hintzen RQ
Biochim Biophys Acta; 2011 Feb; 1812(2):194-201. PubMed ID: 20933079
[No Abstract] [Full Text] [Related]
4. STAT3 in immune responses and inflammatory bowel diseases.
Fu XY
Cell Res; 2006 Feb; 16(2):214-9. PubMed ID: 16474436
[TBL] [Abstract][Full Text] [Related]
5. The autoimmune disease-associated IL12B and IL23R polymorphisms in multiple sclerosis.
Begovich AB; Chang M; Caillier SJ; Lew D; Catanese JJ; Wang J; Hauser SL; Oksenberg JR
Hum Immunol; 2007 Nov; 68(11):934-7. PubMed ID: 18082575
[TBL] [Abstract][Full Text] [Related]
6. [Inflammatory intestinal diseases--a heterogenic group of diseases].
Ranki-Pesonen M
Duodecim; 1995; 111(16):1523-5. PubMed ID: 9273260
[No Abstract] [Full Text] [Related]
7. [Multiple sclerosis].
Offenhäusser M; Martin R
Med Monatsschr Pharm; 1997 Jun; 20(6):149-57. PubMed ID: 9289627
[No Abstract] [Full Text] [Related]
8. Analysis of the T cell receptor V gene usage in multiple sclerosis and human autoimmune thyroiditis.
Ben-Nun A; Bach MA; Raus J; Davies TF
Isr J Med Sci; 1993; 29(2-3):164-7. PubMed ID: 8468172
[No Abstract] [Full Text] [Related]
9. [Analysis of lymphocyte-T receptor in autoimmune diseases].
Lunardi C; Borgato L; De Sandre G
Recenti Prog Med; 1997 Feb; 88(2):82-4. PubMed ID: 9148373
[No Abstract] [Full Text] [Related]
10. Gender bias in autoimmune diseases: X chromosome inactivation in women with multiple sclerosis.
Knudsen GP
J Neurol Sci; 2009 Nov; 286(1-2):43-6. PubMed ID: 19411081
[TBL] [Abstract][Full Text] [Related]
11. [Vitamin D insufficiency--possible etiologic factor of autoimmune diseases].
Jørgensen SP; Bartels LE; Agnholt J; Glerup H; Nielsen SL; Hvas CL; Dahlerup JF
Ugeskr Laeger; 2007 Oct; 169(43):3655-60. PubMed ID: 17967265
[TBL] [Abstract][Full Text] [Related]
12. The interleukin 23 receptor gene in multiple sclerosis: a case-control study.
Roos IM; Kockum I; Hillert J
J Neuroimmunol; 2008 Feb; 194(1-2):173-80. PubMed ID: 18164077
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis: autoimmune associations in multiple sclerosis.
Constantinescu CS; Gran B
Nat Rev Neurol; 2010 Nov; 6(11):591-2. PubMed ID: 21048800
[No Abstract] [Full Text] [Related]
14. CTLA4/CT60 polymorphism is not relevant in susceptibility to autoimmune inflammatory intestinal disorders.
Rueda B; Zhernakova A; López-Nevot MA; Gomez-Garcia M; Ortega E; Piñero A; Correro F; Brieva JA; Nieto A; Koeleman BP; Martín J
Hum Immunol; 2005 Mar; 66(3):321-5. PubMed ID: 15784471
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis. TNFRSF1A, TRAPS and multiple sclerosis.
Kümpfel T; Hohlfeld R
Nat Rev Neurol; 2009 Oct; 5(10):528-9. PubMed ID: 19794511
[TBL] [Abstract][Full Text] [Related]
16. [Autoimmune diseases and multiple sclerosis].
Alemany-Rodríguez MJ; Aladro Y; Amela-Peris R; Pérez-Viéitez MC; Reyes-Yáñez MP; Déniz-Naranjo MC; Sánchez-Garcia F
Rev Neurol; 2005 May 16-31; 40(10):594-7. PubMed ID: 15926131
[TBL] [Abstract][Full Text] [Related]
17. The role of inflammatory bowel disease susceptibility loci in multiple sclerosis and systemic lupus erythematosus.
De Jager PL; Graham R; Farwell L; Sawcer S; Richardson A; Behrens TW; Compston A; Hafler DA; Kere J; Vyse TJ; Rioux JD
Genes Immun; 2006 Jun; 7(4):327-34. PubMed ID: 16642031
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune disease. Twins and T-cell responses.
Kotzin BL
Nature; 1993 Jul; 364(6434):187-8. PubMed ID: 8321313
[No Abstract] [Full Text] [Related]
19. CD44 variant isoforms on blood leukocytes in chronic inflammatory bowel disease and other systemic autoimmune diseases.
Wittig B; Seiter S; Schmidt DS; Zuber M; Neurath M; Zöller M
Lab Invest; 1999 Jun; 79(6):747-59. PubMed ID: 10378517
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production.
Xie L; Li XK; Funeshima-Fuji N; Kimura H; Matsumoto Y; Isaka Y; Takahara S
Int Immunopharmacol; 2009 May; 9(5):575-81. PubMed ID: 19539560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
